Search Within

Howard T Thaler

  1. "Clifford Hudis"
Formats
  1. Journal Article (4)
  2. Meeting Abstract (4)
Groups
  1. Breast Medicine Service (8)
  2. Department of Medicine (8)
  3. Solid Tumor Oncology Division (8)
  4. Survivorship Research (8)
  5. Cardiology (5)
  6. Division of Subspecialty Medicine (5)

More Groups

People
  1. Clifford Hudis (8)
  2. Anthony Yu (5)
  3. Chau Dang (5)
  4. Nandini Yadav (5)
  5. Richard Steingart (5)
  6. Anne Eaton (4)

More People

Years
  1. 2015 (4)
  2. 2013 (1)
  3. 2005 (1)
  4. 2002 (2)
Publications
  1. Cancer Research (3)
  2. Breast Cancer Research and Treatment (1)
  3. Cancer Epidemiology Biomarkers and Prevention (1)
  4. Circulation (1)
  5. Journal of Clinical Oncology (1)
  6. The Oncologist (1)
Publishers
  1. American Association for Cancer Research (4)
  2. American Society of Clinical Oncology (1)
  3. Lippincott Williams & Wilkins (1)
  4. Oxford University Press (1)
  5. Springer (1)

Results (8)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Continuous trastuzumab therapy in breast cancer patients with asymptomatic left ventricular dysfunction
    Journal Article

    Yu, A. F.; Yadav, N. U.; Eaton, A. A.; Lung, B. Y.; Thaler, H. T.; Liu, J. E.; Hudis, C. A.; Dang, C. T.; Steingart, R. M.
    The Oncologist (2015)

    Fulltext@MSK | Save
  • Cardiac safety of continuous trastuzumab therapy in breast cancer patients with asymptomatic left ventricular dysfunction
    Meeting Abstract

    Yu, A. F.; Yadav, N. U.; Eaton, A.; Lung, B. Y.; Thaler, H. T.; Liu, J.; Hudis, C. A.; Dang, C. T.; Steingart, R.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Trastuzumab interruption for treatment-induced cardiotoxicity in HER2 positive early breast cancer
    Meeting Abstract

    Yu, A. F.; Yadav, N. U.; Lung, B. Y.; Eaton, A. A.; Thaler, H. T.; Hudis, C. A.; Dang, C. T.; Steingart, R. M.
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Trastuzumab interruption and treatment-induced cardiotoxicity in early HER2-positive breast cancer
    Journal Article

    Yu, A. F.; Yadav, N. U.; Lung, B. Y.; Eaton, A. A.; Thaler, H. T.; Hudis, C. A.; Dang, C. T.; Steingart, R. M.
    Breast Cancer Research and Treatment (2015)

    Fulltext@MSK | Save
  • Impact of trastuzumab-induced cardiotoxicity and cubsequent trastuzumab interruption on breast cancer outcome
    Meeting Abstract

    Yu, A. F.; Yadav, N. U.; Manrique, C. R.; Thaler, H. T.; Hudis, C. A.; Dang, C. T.; Steingart, R. M.
    Circulation (2013)

    Fulltext@MSK | Save
  • HER2/neu-induced mammary tumorigenesis and angiogenesis are reduced in cyclooxygenase-2 knockout mice
    Journal Article

    Howe, L. R.; Chang, S. H.; Tolle, K. C.; Dillon, R.; Young, L. J. T.; Cardiff, R. D.; Newman, R. A.; Yang, P.; Thaler, H. T.; Muller, W. J.; more...
    Cancer Research (2005)

    Fulltext@MSK | Save
  • The cyclooxygenase-2 inhibitor celecoxib protects against HER2/neu-induced breast cancer
    Meeting Abstract

    Howe, L. R.; Subbaramaiah, K.; Patel, J.; Masferrer, J. L.; Deora, A.; Hudis, C.; Thaler, H. T.; Muller, W. J.; Du, B. H.; Brown, A. M. C.; more...
    Cancer Epidemiology Biomarkers and Prevention (2002)

    Fulltext@MSK | Save
  • Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancer
    Journal Article

    Howe, L. R.; Subbaramaiah, K.; Patel, J.; Masferrer, J. L.; Deora, A.; Hudis, C.; Thaler, H. T.; Muller, W. J.; Du, B. H.; Brown, A. M. C.; more...
    Cancer Research (2002)

    Fulltext@MSK | Save